SPTLC2 and amyotrophic lateral sclerosis: Although juvenile ALS is defined by onset of upper and lower motor neuron degeneration and related symptoms before 25 years of age, SPTLC1 and SPTLC2-associated ALS together form a distinct, early childhood onset subgroup of neurodevelopmental motor neuron disease with typical onset of disease in the first few years of life.